000			02113 a2200589 4500
005			20250517130420.0
264		0	_c20180226
008			201802s 0 0 eng d
022			_a2567-689X
024	7		_a10.1160/TH16-09-0731 _2doi
040			_aNLM _beng _cNLM
100	1		_aJakubowski, Joseph A
245	0	0	_aReal-time dose adjustment using point-of-care platelet reactivity testing in a double-blind study of prasugrel in children with sickle cell anaemia. _h[electronic resource]
260			_bThrombosis and haemostasis _c02 2017
300			_a580-588 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAnemia, Sickle Cell _xblood
650	0	4	_aBlood Platelets _xdrug effects
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Dosage Calculations
650	0	4	_aDrug Monitoring _xmethods
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aPlatelet Aggregation Inhibitors _xadministration & dosage
650	0	4	_aPlatelet Function Tests
650	0	4	_aPoint-of-Care Testing
650	0	4	_aPrasugrel Hydrochloride _xadministration & dosage
650	0	4	_aPredictive Value of Tests
650	0	4	_aPurinergic P2Y Receptor Antagonists _xadministration & dosage
650	0	4	_aReceptors, Purinergic P2Y12 _xblood
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aVascular Diseases _xblood
700	1		_aHoppe, Carolyn C
700	1		_aZhou, Chunmei
700	1		_aSmith, Brendan E
700	1		_aBrown, Patricia B
700	1		_aHeath, Lori E
700	1		_aInusa, Baba
700	1		_aRees, David C
700	1		_aSmall, David S
700	1		_aGupta, Neehar
700	1		_aYao, Suqin
700	1		_aHeeney, Matthew
700	1		_aKanter, Julie
773	0		_tThrombosis and haemostasis _gvol. 117 _gno. 3 _gp. 580-588
856	4	0	_uhttps://doi.org/10.1160/TH16-09-0731 _zAvailable from publisher's website
999			_c26676711 _d26676711